Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07525505 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nigella Sativa Oil for Eczematous Otitis Externa

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 21, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment openedv3 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Apr 2026 to Jan 12, 2026
    • Interventions: Mometasone Furoate (MF) (Drug), Nigella sativa oil (Dietary Supplement) to Mometasone Furoate (MF) (Drug), Nigella sativa oil (Drug)
    • Study title shortened, about 3 words
  2. Study title expanded, about 1 wordv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Eczematous otitis externa is a common inflammatory condition of the external auditory canal characterized by itching, discomfort, discharge, and pain. Topical corticosteroids are widely used for treatment; however, alternative therapies with fewer side effects are of increasing interest. This study aims to compare the efficacy of Nigella sativa (black seed) oil and mometasone furoate ear drops in the treatment of eczematous otitis externa. Nigella sativa is a natural product with known anti-inflammatory and antimicrobial properties. In this randomized, controlled clinical trial, adult patients with eczematous otitis externa will be assigned to receive either Nigella sativa oil or mometasone furoate ear drops for 10 days. Clinical symptoms and inflammatory findings will be evaluated at baseline and after treatment. The objective of this study is to determine whether Nigella sativa oil is an effective and safe alternative to topical corticosteroid therapy.
Trial Details
NCT Number NCT07525505
Lead Sponsor Bezmialem Vakif University
Conditions
(from sponsor)		 Eczema/Atopic Dermatitis, Otitis Externa
Related terms Dermatitis, Atopic, Eczema, Otitis Externa
Enrollment 85 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov